Guj. Terce Labs.

27
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE499G01013
  • NSEID:
  • BSEID: 524314
INR
48.90
0.1 (0.2%)
BSENSE

Dec 23

BSE+NSE Vol: 252

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.63% vs 2.55% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 206.49% vs 158.58% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -38.55% vs -6.29% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -501.93% vs 114.57% in Mar 2024

Compare Profit and Loss Results of Guj. Terce Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
50.00
120.00
-70.00
-58.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
50.00
120.00
-70.00
-58.33%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-4.00
4.00
100.00%
Raw Materials Consumed
19.00
114.00
-95.00
-83.33%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
16.00
3.00
13.00
433.33%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
0.00
4.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
46.00
116.00
-70.00
-60.34%
Operating Profit (PBDIT) excl Other Income
3.00
4.00
-1.00
-25.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
4.00
6.00
-2.00
-33.33%
Interest
0.00
2.00
-2.00
-100.00%
Profit before Depriciation and Tax
3.00
3.00
0.00
0.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
3.00
2.00
1.00
50.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
3.00
2.00
1.00
50.00%
Provision for Tax
4.00
0.00
4.00
0%
Profit After Tax
0.00
2.00
-2.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-2.00
7.00
-9.00
-128.57%
Profit Available for appropriations
-3.00
9.00
-12.00
-133.33%
Appropriations
-3.00
9.00
-12.00
-133.33%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-1.32
2.57
-3.89
-151.36%
Profit And Loss - Net Sales
Net Sales 50.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.63% vs 2.55% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 206.49% vs 158.58% in Mar 2024

Profit And Loss - Interest
Interest 0.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -38.55% vs -6.29% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -0.98 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -501.93% vs 114.57% in Mar 2024